Use Evolving oncology diagnosis, prognosis & precision medicine
65 James St,
Edison NJ 08820
Don’t accept partial results.
Cancer is a complex disease requiring comprehensive answers. Only a comprehensive answer will allow medical professionals to make the highest quality care decisions for their patients. At Anthology Diagnostics we analyze both DNA and RNA which gives the best possible answers based on our current knowledge.
Anthology Diagnostics Provides Comprehensive Answers
Both solid tumors (lung, colon, breast, etc) and hematologic malignancies (leukemia, multiple myeloma, etc) have molecular profiling tests available. All major types of cancer have molecular testing that can be performed on them but the sample requirements will be different.
Machine and Deep Learning Meets Next Generation Sequencing
Anthology Diagnostics was founded in partnership with Hackensack Meridian Health and Genomic Testing Cooperative to bring comprehensive genomic profiling for cancer to the local New Jersey community and east coast.
Anthology Diagnostics operates out of the JFK Medical Center and serves physicians, patients, hospitals and local labs to help advance precision medicine.
We provide tumor profiling for solid tumors and hematologic malignancies. Liquid biopsy testing is also available.
Anthology Diagnostics offers local state-of-the-art genomic profiling analyzing both DNA and RNA.
Our Precision Diagnostics offering utilizes the most advanced technology and software with deep learning to deliver advances in disease detection, prognosis and therapy recommendations. Our high-quality testing requires less tissue, provides faster results and is more cost efficient and affordable.
Anthology Diagnostics molecular profile tests are well validated and covered by Medicare and most major insurances.
Anthology Diagnostics is part of the Genomic Testing Cooperative network of laboratories.
GTC in collaboration with Anthology Diagnostics allows laboratories, health systems and Oncology groups to join this network, share resources, share knowledge, and collaborate in a community environment.
The GTC model produces big data for AI analysis creating value for hospitals, research, drug development, and others involved in cancer care.